0001209191-20-049303.txt : 20200903 0001209191-20-049303.hdr.sgml : 20200903 20200903125307 ACCESSION NUMBER: 0001209191-20-049303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200901 FILED AS OF DATE: 20200903 DATE AS OF CHANGE: 20200903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stewart Christopher P. CENTRAL INDEX KEY: 0001822991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38613 FILM NUMBER: 201158825 MAIL ADDRESS: STREET 1: C/O BIONANO GENOMICS, INC. STREET 2: 9540 TOWNE CENTRE DRIVE, SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bionano Genomics, Inc CENTRAL INDEX KEY: 0001411690 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 261756290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 888-7600 MAIL ADDRESS: STREET 1: 9540 TOWNE CENTRE DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BioNano Genomics, Inc DATE OF NAME CHANGE: 20120703 FORMER COMPANY: FORMER CONFORMED NAME: BioNanomatrix Inc DATE OF NAME CHANGE: 20070906 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-01 0 0001411690 Bionano Genomics, Inc BNGO 0001822991 Stewart Christopher P. C/O BIONANO GENOMICS, INC. 9540 TOWNE CENTRE DRIVE, SUITE 100 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 0.56 2020-09-01 4 A 0 350000 0.00 A 2030-09-01 Common Stock 350000 350000 D Stock Option (Right to Buy) 0.56 2020-09-01 4 A 0 225000 0.00 A 2030-09-01 Common Stock 225000 225000 D 25% of the shares subject to the stock option vest and become exercisable on September 1, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such applicable vesting date and the terms of the Issuer's 2020 Inducement Plan, subject to acceleration of vesting as provided for in that certain Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person. The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person. /s/ R. Erik Holmlin, Attorney-in-Fact 2020-09-03